Humacyte, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2382 USD
−148.70 M USD
0.00 USD
163.95 M
About Humacyte, Inc.
Sector
Industry
CEO
Laura E. Niklason
Website
Headquarters
Durham
Founded
2004
Identifiers
3
ISIN US44486Q1114
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Displays a symbol's price movements over previous years to identify recurring trends.